Education
About Us
Working with TipRanks
Follow Us
Palatin Technologies (PTNT)
OTHER OTC:PTNT
Earnings Data
Report Date
Feb 17, 2026Before Open (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
―Last Year’s EPS
-0.12Same Quarter Last Year
Based on 0 Analysts Ratings
Earnings Call Summary
Q1 2026
Earnings Call Date:Nov 13, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call highlighted significant achievements, such as the successful collaboration with Boehringer Ingelheim, a return to NYSE American listing, and strong financial performance with increased revenue and net income. However, concerns about the reduced cash position and dependency on future milestones were noted. Overall, the positive aspects of strategic partnerships and financial recovery outweigh the concerns.Company Guidance
Successful Collaboration with Boehringer Ingelheim
Palatin executed a research collaboration, license, and patent assignment agreement with Boehringer Ingelheim for the treatment of retinal diseases, receiving an upfront payment of approximately $2.3 million and achieving a research milestone of approximately $6.5 million.
Resumption of NYSE American Listing
Palatin's common stock resumed trading on the NYSE American under the symbol PTN after closing an upsized $18.2 million underwritten public offering.
Significant Revenue Increase
Palatin recognized approximately $8.8 million in collaboration license revenue for the quarter ended September 30, 2025, compared to $0 for the comparable quarter last year, primarily due to the Boehringer Ingelheim agreement.
Net Income Achieved
Palatin reported net income of $4.7 million for the quarter ended September 30, 2025, compared to a net loss of $7.8 million for the comparable quarter last year.
R&D Focus on Melanocortin-4 Receptor Agents
Palatin is developing selective melanocortin-4 receptor agents for obesity treatment, with plans for investigational new drug application filings and clinical studies in 2026.
PTNT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
PTNT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 13, 2025 | $11.04 | $10.80 | -2.17% |
Oct 07, 2025 | $7.90 | $7.27 | -7.97% |
May 14, 2025 | $4.57 | $5.25 | +14.88% |
Feb 13, 2025 | $49.48 | $53.00 | +7.11% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Palatin Technologies (PTNT) report earnings?
Palatin Technologies (PTNT) is schdueled to report earning on Feb 17, 2026, Before Open (Confirmed).
What is Palatin Technologies (PTNT) earnings time?
Palatin Technologies (PTNT) earnings time is at Feb 17, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is PTNT EPS forecast?
Currently, no data Available